IMMUNOREACTIVE FORMS OF PANCREATIC STONE PROTEIN IN 6 MAMMALIAN-SPECIES

被引:20
作者
BERNARD, JP
ADRICH, Z
MONTALTO, G
MULTIGNER, L
DAGORN, JC
SARLES, H
DECARO, A
机构
[1] Unité de Recherches de Physiologie et Pathologie Digestives, INSERM, Marseille
关键词
PANCREATIC STONE PROTEIN; MAMMALS; CALCIUM PRECIPITATION;
D O I
10.1097/00006676-199103000-00006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Secretory forms of the pancreatic stone protein (PSP S, Mr 17, 500-22,000) have been purified from human pancreatic juice. PSP S are inhibitors of CaCO3 crystal growth. The presence of similar proteins in bovine, canine, monkey, porcine, and rat pancreatic secretion was investigated in terms of biological role and immunological relationship. Pancreatic proteins were analyzed by electrophoretic separation and by subsequent immunoblotting with a rabbit polyclonal antibody against human PSP. A single immunoreactive form was detected in dog, pig, and rat (Mr 17,000), and two distinct immunoreactive forms were observed in cow and monkey (Mr 15,000 and 17,000). Inhibition of CaCO3 crystal growth was demonstrated in dog and rat. Further kinetic studies of the inhibition process in the rat showed that PSP S binds to the crystal surface according to a Langmuir adsorption isotherm with a dissociation constant (Kd) of 1.5 x 10(-6) M. These results suggest that proteins homologous to human PSP S are present in other mammalian species and may act as stabilizers of Ca2+ -supersaturated pancreatic juice.
引用
收藏
页码:162 / 167
页数:6
相关论文
共 21 条
  • [1] De Caro A., Lohse J., Sarles H., Characterization of a protein isolated from pancreatic calculi of men suffering from chronic calcifying pancreatitis, Biochem Biophys Res Commun, 87, pp. 1176-1182, (1979)
  • [2] De Caro A., Multigner L., Lafont H., Lombardo D., Sarles H., The molecular characteristics of a human pancreatic acidic phosphoprotein that inhibits calcium carbonate crystal growth, Biochem J, 222, pp. 669-677, (1984)
  • [3] Montalto G., Bonicel J., Multigner L., Rovery M., Sarles H., De Caro A., Partial amino acid sequence of human pancreatic stone protein, a novel pancreatic secretory protein, Biochem J, 238, pp. 227-232, (1986)
  • [4] De Caro A., Bonicel J Rouimi P., De Caro J., Sarles H., Rovery M., Complete amino acid sequence of an immunoreactive form of human pancreatic stone protein isolated from pancreatic juice, Eur J Biochem, 168, pp. 201-207, (1987)
  • [5] Rouimi P., Bonicel J., Rovery M., De Caro A., Cleavage of the Arg He bond in the native polypeptide chain of human pancreatic stone protein, FEBS Lett, 216, pp. 195-199, (1987)
  • [6] De Caro A., Adrich Z., Fournet B., Capon C., Bonicel J., De Caro J., Rovery M., N-terminal sequence extension in the glycosylated forms of human pancreatic stone protein. The 5 oxoproline N terminal chain is 0-glycosylated on the 5th amino acid residue, Biochim Biophys Acta, 994, pp. 281-284, (1989)
  • [7] Giorgi D., Bernard J.P., Rouquier S., Iovanna J., Sarles H., Dagorn J.C., Secretory pancreatic stone protein messenger RNA. Nucleotide sequence and expression in chronic calcifying pancreatitis, J Clin Invest, 84, pp. 100-106, (1989)
  • [8] Provansal Cheylan M., Mariani A., Bernard J.P., Sarles H., Pancreatic stone protein: Quantification in pancreatic juice by enzyme linked immunosorbent assay and comparison with other methods, Pancreas, 4, pp. 680-689, (1989)
  • [9] Verine H., Recherches sur la lithog6nese amcreatique, Apports De La Pathologie Compared Et De La Lithogenese Experimentale, (1973)
  • [10] Konishi K., Izumi R., Kato O., Yamaguchi A., Miyasaki I., Experimental pancreatolithiasis in the dog, Surgery, 89, pp. 687-691, (1981)